Neogenomics Inc (NEO)

Jul 1, 2025, 7:05 AM EDT - 12 days ago

NeoGenomics to Report Second Quarter 2025 Financial Results on July 29, 2025

Jun 30, 2025, 7:05 AM EDT - 13 days ago

NeoGenomics Announces PanTracer Tissue and PanTracer Tissue + HRD Now Available to Support More Informed and Timely Cancer Care

Jun 24, 2025, 7:05 AM EDT - 19 days ago

NeoGenomics Appoints Dr. Marjorie Green to Board of Directors

May 28, 2025, 7:10 AM EDT - 6 weeks ago

NeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025

May 22, 2025, 7:10 AM EDT - 7 weeks ago

NeoGenomics Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung Cancer

May 20, 2025, 7:05 AM EDT - 7 weeks ago

NeoGenomics to Participate in Upcoming June Investor Conferences

May 1, 2025, 7:05 AM EDT - 2 months ago

NeoGenomics Pays Off 1.25% Convertible Senior Notes

Apr 30, 2025, 9:00 AM EDT - 2 months ago

NeoGenomics Q1 Earnings: The Stock Price Drop Is A Gift (Rating Upgrade)

Apr 29, 2025, 12:18 PM EDT - 2 months ago

NeoGenomics, Inc (NEO) Q1 2025 Earnings Call Transcript

Apr 29, 2025, 8:00 AM EDT - 2 months ago

NeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in Oncology using the UG 100 sequencing platform

Apr 29, 2025, 7:30 AM EDT - 2 months ago

NeoGenomics Reports First Quarter 2025 Results

Apr 22, 2025, 7:05 AM EDT - 2 months ago

NeoGenomics to Showcase PanTracer LBx Validation Study at AACR Annual Meeting

Apr 8, 2025, 7:05 AM EDT - 3 months ago

NeoGenomics to Report First Quarter 2025 Financial Results on April 29, 2025

Apr 7, 2025, 7:05 AM EDT - 3 months ago

NeoGenomics Completes Acquisition of Pathline

Apr 1, 2025, 7:05 AM EDT - 3 months ago

Tony Zook Assumes Role as Chief Executive Officer of NeoGenomics

Mar 10, 2025, 7:00 AM EDT - 4 months ago

NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline

Feb 28, 2025, 3:39 AM EST - 4 months ago

NeoGenomics: Decent Fundamentals, But Still Overvalued

Feb 24, 2025, 7:05 AM EST - 4 months ago

NeoGenomics to Participate in Upcoming Investor Conferences

Feb 18, 2025, 12:22 PM EST - 5 months ago

NeoGenomics, Inc (NEO) Q4 2024 Earnings Call Transcript

Feb 18, 2025, 7:05 AM EST - 5 months ago

NeoGenomics Reports Fourth Quarter and Full Year 2024 Results

Jan 29, 2025, 8:05 AM EST - 5 months ago

NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025

Jan 15, 2025, 7:05 AM EST - 6 months ago

NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan

Jan 10, 2025, 7:05 AM EST - 6 months ago

NeoGenomics Announces Chief Executive Officer Succession

Jan 6, 2025, 7:55 AM EST - 6 months ago

NeoGenomics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Dec 11, 2024, 8:05 AM EST - 7 months ago

NeoGenomics' Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma

Dec 9, 2024, 8:10 AM EST - 7 months ago

NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting

Dec 5, 2024, 7:00 AM EST - 7 months ago

ConcertAI and NeoGenomics Announce New AI Software-as-a-Service Solution for Hematology Clinical Research

Nov 19, 2024, 8:15 AM EST - 8 months ago

NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment

Nov 14, 2024, 8:10 AM EST - 8 months ago

Felicia Williams Joins NeoGenomics Board of Directors

Nov 8, 2024, 7:00 AM EST - 8 months ago

NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nov 5, 2024, 1:27 PM EST - 8 months ago

NeoGenomics, Inc. (NEO) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 7:00 AM EST - 8 months ago

NeoGenomics Reports Third Quarter 2024 Results

Oct 22, 2024, 8:10 AM EDT - 9 months ago

NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test

Oct 15, 2024, 7:30 AM EDT - 9 months ago

NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024

Oct 8, 2024, 8:10 AM EDT - 9 months ago

NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia

Oct 2, 2024, 12:10 PM EDT - 10 months ago

NeoGenomics Inc (NEO) Shares Up 3.95% on Oct 2

Sep 23, 2024, 6:47 PM EDT - 10 months ago

NeoGenomics Announces New RaDaR Technology and Resolution of RaDaR 1.0 Litigation

Sep 11, 2024, 8:05 AM EDT - 10 months ago

NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment

Aug 29, 2024, 8:05 AM EDT - 11 months ago

NeoGenomics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Jul 29, 2024, 8:14 PM EDT - 1 year ago

NeoGenomics, Inc. (NEO) Q2 2024 Earnings Call Transcript

Jul 29, 2024, 4:05 PM EDT - 1 year ago

NeoGenomics Reports Second Quarter 2024 Results

Jul 9, 2024, 7:00 AM EDT - 1 year ago

NeoGenomics to Report Second Quarter 2024 Financial Results on July 29, 2024

Jun 13, 2024, 8:00 AM EDT - 1 year ago

Fort Myers' Mayor to Proclaim June as NeoGenomics' Commitment to Cancer Month

Jun 10, 2024, 1:00 AM EDT - 1 year ago

Press release Biocartis NV: Biocartis Welcomes Gina Wallar, PhD as Chief Business Officer and Judith Vacchino, PhD as VP Global Marketing

FLGT

May 28, 2024, 8:05 AM EDT - 1 year ago

NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management

Apr 30, 2024, 2:11 PM EDT - 1 year ago

NeoGenomics, Inc. (NEO) Q1 2024 Earnings Call Transcript

Apr 30, 2024, 7:30 AM EDT - 1 year ago

NeoGenomics Reports First Quarter 2024 Results

Apr 18, 2024, 7:05 AM EDT - 1 year ago

NeoGenomics Announces Senior Leadership Promotions